

Fundamental dimension Equity attribute | BMHLLeader $3.39▼-0.29% Cap $86.51MP/E 66.5x QuantScore49/100 | GECCPeer $4.75▼-1.04% Cap $65.98MP/E -1.5x QuantScore40/100 | GRANPeer $1.16▲+0.87% Cap $28.98MP/E -63.7x QuantScore33/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
53/100 |
23/100 |
39/100 |
Valuation Multiples, PEG & DCF upside | 25/100 | 50/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 79/100 | 27/100 | 50/100 |
Growth Revenue / earnings growth & margins | 38/100 | 50/100 | 12/100 |
Sentiment Analyst ratings, targets & revisions | — | 50/100 | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 66.5x | -1.5x | -63.7x |
Forward P/E (next FY) | — | 5.1x | — |
EV / EBITDA (TTM) | 242.0x | -6.8x | -230.3x |
Price / Sales | 10.9x | -4.4x | 87.7x |
Price / Free Cash Flow | -7.5x | 1.2x | -307.7x |
PEG ratio | 0.66 | 0.05 | 0.55 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 6 / 9 | 1 / 9 |
Altman Z-Score | 34.88 (Safe) | -1.45 (Distress) | 26.67 (Safe) |
Total debt / equity | 0.04 | 1.47 | 0.06 |
Quick ratio | 6.0x | 1.5x | 0.5x |
Interest coverage | 13.5x | -2.2x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +15.9% | +90.2% | -92.4% |
Net income growth YoY | +10.8% | -994.7% | -127.5% |
Gross margin (TTM) | 25.9% | 187.3% | 43.7% |
Operating margin (FY) | 4.6% | -28.8% | -53.0% |
FCF margin (FY) | -146.7% | -6.3% | -28.5% |
5. Trailing price performancePrice change over period |
1M return | -33.7% | -10.0% | +4.5% |
3M return | -39.8% | -9.0% | -7.9% |
6M return | -5.3% | -14.4% | +11.5% |
Year to date | +1.8% | -32.6% | -75.9% |
1Y return | -0.3% | -39.8% | -61.7% |
3Y return | -15.3% | -44.8% | -74.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $0.8807 -74.0% premium | $-17.75 -473.7% premium | $0.0363 -96.9% premium |
Wall Street consensus target | — — | $11.00 +131.6% · range $11.00–$11.00 | — — |
Consensus stance | — | 0% Buy100% Hold0% Sell | — |